Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Insulin: A Novel Therapy for Hypoglycemia Unawareness in Type 1 Diabetes

NCT04028960 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT04028960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04028960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Insulin: A Novel Therapy for Hypoglycemia Unawareness in Type 1 Diabetes
Lead sponsor
HealthPartners Institute
Phase
Phase 2
Overall status
Terminated
Start date
October 23, 2019
Completion date
April 8, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type1diabetes